v3.26.1
NON CONTROLLING INTEREST (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Net loss $ (1,001,706) $ (1,011,092) $ (1,377,276) $ (851,764) $ (2,012,798) $ (2,229,040)
Net loss attributable to the non-controlling interest (36,932)   (143,858)   (102,188) (154,215)
BioCorRx Pharmaceuticals, Inc [Member]            
Net loss $ (269,652)   $ (42,784)   $ (287,410) $ (594,446)
Average Non-controlling interest percentage of profit/losses 24.20%   24.20%   12.85% 24.20%
Net loss attributable to the non-controlling interest $ (65,256)   $ (10,354)   $ 36,932 $ (143,856)
Total         (102,188) (154,210)
Joseph DeSanto MD [Member]            
Net loss $ 0   $ (10)   $ 0 $ (5)
Average Non-controlling interest percentage of profit/losses 35.00%   35.00%   35.00% 35.00%
Net loss attributable to the non-controlling interest $ 0   $ (3)   $ 0 $ (2)
Total         $ 0 $ (5)